There's a pretty good chance Warren Buffett knows a few things about investing that we don't. Let's take a look at three of his most likely arguments against buying biotechs. Biotech stocks are risky, and there isn't really any way of de-risking their line of business, both of which are things that Buffett almost certainly hates about them.